Safety and Activity Study of an Oral Medication to Treat Moderate to Severe Crohn's Disease

• Status: Completed
• Trial end date: 2005-12-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this research study is to investigate the effects of an investigational medication, called CCX282-B, on safety and on the some of the symptoms of Crohn's Disease in patients who are experiencing an active flare-up of moderate to severe Crohn's Disease.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: ChemoCentryx

Criteria

Inclusion Criteria:

• Diagnosis of moderate to severe Crohn's Disease in small intestine; disease must be active at the time of study entry

• Use of adequate and approved methods of birth control throughout the study period

• Willing and able to sign an informed consent

Exclusion Criteria:

• Pregnant or breastfeeding

• Infection with hepatitis B, hepatitis C, or human immunodeficiency virus (HIV; the virus that causes AIDS)

• Abuse of alcohol or of illegal drugs